BioCentury
ARTICLE | Clinical News

Durvalumab: Ph Ib started

December 1, 2016 11:43 AM UTC

OncoPep Inc. (North Andover, Mass.) began an open-label, U.S. Phase Ib trial to compare PVX-410 plus IV durvalumab with or without Revlimid lenalidomide vs. durvalumab alone in about 26 patients. Pati...